Hormone replacement therapy
Details for Australian Patent Application No. 2002336245 (hide)
International Classifications
Event Publications
20 February 2003 Complete Application Filed
Priority application(s): 60/276,575 16.03.01 US
27 March 2003 Application Open to Public Inspection
Published as AU-B-2002336245
22 March 2007 Application Accepted
Published as AU-B-2002336245
19 July 2007 Standard Patent Sealed
14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002336246-Nebulizer having cooling chamber
2002336244-A NOVEL TRP2 ISOFORM CONTAINING HLA-A2 RESTRICTED CYTOTOXIC T LYMPHOCYTE EPITOPES
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser